Detailed Product Description
Hemosure?, an one-step, easy to use product
developed by Hemosure, Inc. based on its years of clinical study,
is the latest technological breakthrough in Immunological Fecal
Occult Blood Testing (IFOBT), and it is both FDA approved and CLIA
waived. Hemosure? employs a unique combination
of monoclonal and polyclonal antibodies to detect only human blood
in stool. As a result, abstinence of food and drug before taking
this test is no longer necessary. These advantages can
significantly enhance patient compliances.
In addition to the inherent specificity and sensitivity,
Hemosure? test can be performed by health care
providers in hospitals, labs and private practices. No need to send
fecal samples to the laboratory. Doctors can easily, quickly and
accurately read the test results in less than 5 minutes. This new
technology has greatly improved specificity, sensitivity, accuracy
and cost-effectiveness of the fecal occult blood tests.
Hemosure? has unquestionably set a new standard
on how future fecal occult blood testing is carried out.
|